ADVFN US – Market Content Editor
-

Cassava Sciences gains as DOJ ends probe into research misconduct claims
Cassava Sciences (NASDAQ:SAVA) shares advanced 2.75% on Thursday after the biotech firm disclosed that the U.S. Department of Justice has formally closed its investigation into allegations of research misconduct. The inquiry stemmed from claims outlined in the indictment in United States v. Wang, a case the DOJ dismissed with prejudice on October 23, 2025. The…
-

Kinetik shares climb on reported takeover approach from Western Midstream
Kinetik Holdings Inc (NYSE:KNTK) moved higher in premarket trading Thursday, gaining about 3.6%, after a report indicated the company is evaluating a possible sale following unsolicited interest from Western Midstream Partners. According to the Financial Times, which cited people familiar with the matter, the $7.2 billion midstream operator has begun assessing strategic alternatives after being…
-

Wayfair stock slips despite Q4 earnings beat
Wayfair Inc. (NYSE:W) delivered fourth-quarter results that topped profit expectations, but the market reaction was muted, with shares edging lower in premarket trading as investors weighed the company’s broader performance and outlook. The online home goods retailer reported adjusted earnings per share of $0.85, comfortably ahead of the $0.68 analysts had forecast. Revenue totaled $3.3…
-

Southern Company tops revenue forecasts, shares edge higher despite EPS miss
Southern Company (NYSE:SO) reported mixed fourth-quarter results on Thursday, missing earnings expectations but delivering stronger-than-anticipated revenue growth, sending the stock nearly 2.5% higher in premarket trading. The U.S. utility group posted adjusted earnings of $0.55 per share for the fourth quarter of 2025, slightly below the $0.57 consensus estimate. However, revenue climbed to $7.0 billion,…
-

Quanta Services climbs after Q4 beat and strong 2026 outlook
Quanta Services, Inc. (NYSE:PWR) moved more than 4% higher in premarket trading Thursday after the infrastructure engineering group delivered better-than-expected fourth-quarter results and issued bullish guidance for 2026. The company reported adjusted earnings of $3.16 per share for the final quarter of 2025, topping analyst estimates of $3.02. Revenue surged to a record $7.84 billion,…
-

Visteon slips despite Q4 beat as 2026 revenue outlook disappoints
Visteon Corporation (NASDAQ:VC) posted fourth-quarter results that topped Wall Street forecasts, but shares declined nearly 4% in premarket trading after the company issued softer-than-expected revenue guidance for 2026. The automotive technology supplier reported adjusted earnings per share of $2.96 for the quarter, well above the consensus estimate of $2.08. Revenue rose to $948 million, beating…
-

UL Solutions tops Q4 forecasts, boosts dividend as margins expand
UL Solutions Inc. (NYSE:ULS) delivered better-than-expected fourth-quarter results, driven by steady organic growth and sharp margin expansion, and announced a double-digit dividend increase. For the quarter, adjusted earnings per share came in at $0.53, beating analyst estimates by $0.12. Revenue rose 6.8% year over year to $789 million, supported by solid demand across its Consumer…
-

N-able jumps more than 9% as revenue beat and 2026 outlook offset EPS shortfall
N-able, Inc. (NYSE:NABL) shares climbed 9.66% in after-hours trading Thursday after the cybersecurity software provider delivered stronger-than-expected fourth-quarter revenue and issued upbeat guidance for 2026, despite missing earnings forecasts. The company reported Q4 revenue of $130.3 million, ahead of the $127.02 million consensus estimate and up 11.8% year over year. Adjusted earnings per share came…
-

Klarna tops $1 billion in quarterly revenue as U.S. growth accelerates
Klarna (NYSE:KLAR) posted fourth-quarter 2025 revenue of $1.082 billion, its first quarter surpassing the $1 billion mark, as strong expansion in the U.S. fueled overall growth. Revenue rose 38% year over year, ahead of company guidance, while gross merchandise volume (GMV) climbed 32% to $38.7 billion, exceeding the upper end of management’s forecast. The United…
-

Madrigal slides more than 5% as wider Q4 loss tempers strong sales growth
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares fell 5.39% in premarket trading Thursday after the company reported fourth-quarter results that topped revenue expectations but delivered a larger-than-forecast loss. The biotechnology firm, which develops therapies for metabolic dysfunction-associated steatohepatitis (MASH), posted quarterly revenue of $321.1 million, ahead of the $310.82 million consensus estimate. However, earnings per share came…